University
Rawalpindi, Punjab Province, 46000, Pakistan
NCT Number: NCT07604012
The goal of this clinical trial (randomized controlled trial) is to examine the effectiveness of a holistic lifestyle mHealth intervention in reducing the risk of type 2 diabetes mellitus.
The study focuses on young adults aged 20-35 years, recruited from public and private universities in Rawalpindi and Islamabad, who meet the defined inclusion criteria.
The main questions it aims to answer are:
Does a holistic lifestyle mHealth intervention significantly reduce the risk of type 2 diabetes ? Does the intervention improve overall health-related quality of life and lifestyle behaviors, including diet, physical activity, and stress management?
Trial opening soon.
Get Notified20 year–35 year
All sexes
Interventional
Not applicable
Rawalpindi, Punjab Province, 46000, Pakistan
Researchers will compare participants receiving the holistic lifestyle mHealth intervention (based on "Eat Well, Move More, Stress Less") with a control group receiving standard care or basic health guidance to see if the intervention leads to greater reduction in diabetes risk and improved health outcomes.
Participants will:
Use a culturally tailored mHealth application designed for the Pakistani context Follow lifestyle recommendations focused on diet, physical activity, and stress management Engage with intervention content based on the three core pillars: Eat Well, Move More, Stress Less Participate in periodic assessments, including health measurements and questionnaires Provide feedback on their experience and adherence to the intervention
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The main components of the holistic mHealth intervention include the following: nutritional education, promotion of physical activity, sleep education, and behavioral health support. The integration of these components in mHealth promotes a holistic lifestyle through enhancing overall health-related quality of life.
Other names: mHealth App, mhealth Intervention, Holistic Intervention
Time frame: 6-8 weeks
Measured using a validated tool, the Short Form Health Survey (SF-36), assessed at baseline and post-intervention. The primary endpoint is the difference in mean risk scores between the intervention and control groups.
score ≤ 44 indicates weak, 45-63 indicate medium, ≥ 64 indicate good.
Time frame: 8 weeks
Diabetes risk assessment is assessed through RAPID (Risk Assessment of Pakistani Individual for Diabetes) .
Changes in blood glucose levels assessd through HbA1c measured in mg/dL at baseline and post-intervention.
Time frame: 8 weeks
Food literacy measured by using Self-Perceived Food Literacy Scale Short Form Scoing : <30.6 indicates inadequate-limited food literacy; >31 indicates adequate-excellent food literacy.
Time frame: 8 weeks
Eating Behavior measured by using Self-Regulation of Eating Behavior Questionnaire for Adults. Scoring: <2.8 indicate Low level, 2.8 to 3.6 indicate Medium>3.6High
Time frame: 8 weeks
weight will be combined to report BMI in kg/m^2.
Time frame: 8 weeks
Sleep Quality measured by Pittsburgh Sleep Quality Index (PSQI) Scoring
:0 - No sleep difficulties; 5 or higher - Poor sleep quality
Time frame: 8 weeks
Psychological Distress will be measured by using Depression, Anxiety and Stress Scale (DASS-21)
Scoring:
Depression : 0-9 normal ,14-20 moderate , 28+ severe Anxiety : 8-9 mild , 10-14 moderate Stress: 15-18 mild, 19-25 moderate
Contact information is provided by the study sponsor or research team.
Anmol Ayaz, Phd Scholar
CONTACT
Sajida Naz Dr
CONTACT
Fatima Jinnah Women University
Other
Effectiveness of Holistic Lifestyle mHealth Intervention for Risk Reduction of Type 2 Diabetes Mellitus in Young Adults: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07675551
Behavior, Behavior, Animal
Brampton, Ontario, Canada
View Trial DetailsNCT07581106
Autoimmune Diseases, Behavior
View Trial DetailsNCT05925946
Behavior, Behavior, Animal
View Trial DetailsNCT07609290
Behavior, Diabetes Mellitus
Tainan, Yongkang Dist, Taiwan
View Trial Details